CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer

Table 4

Univariate and multivariate analysis of progress-free interval in patients with ovarian cancer.

Characteristics	Total ()	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)	value	Hazard ratio (95% CI)	value
Age	377
≤60	206	Reference
>60	171	1.076 (0.848-1.366)	0.547
FIGO stage	374
Stage I and stage II	24	Reference
Stage III and stage IV	350	1.573 (0.918-2.694)	0.099	1.573 (0.918-2.694)	0.099
Histologic grade	367
G1 and G2	46	Reference
G3 and G4	321	1.188 (0.835-1.688)	0.338
Lymphatic invasion	148
No	48	Reference
Yes	100	1.115 (0.729-1.704)	0.615
CLDN4	377
Low	187	Reference
High	190	1.183 (0.933-1.500)	0.165